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ABSTRACT 
BACKGROUND 
Studies suggest that alcohol consumption and alcohol use disorders have distinct genetic 
backgrounds. 
 
METHODS 
We examined whether polygenic risk scores (PRS) for consumption and problem subscales of 
the Alcohol Use Disorders Identification Test (AUDIT-C, AUDIT-P) in the UK Biobank (UKB; 
N=121,630) correlate with alcohol outcomes in four independent samples: an ascertained 
cohort, the Collaborative Study on the Genetics of Alcoholism (COGA; N=6,850), and 
population-based cohorts: Avon Longitudinal Study of Parents and Children (ALSPAC; 
N=5,911), Generation Scotland (GS; N=17,461), and an independent subset of UKB 
(N=245,947). Regression models and survival analyses tested whether the PRS were 
associated with the alcohol-related outcomes. 
 
RESULTS                                               
In COGA, AUDIT-P PRS was associated with alcohol dependence, AUD symptom count, 
maximum drinks (R2=0.47% - 0.68%, p=2.0e-8 - 1.0e-10), and increased likelihood of onset of 
alcohol dependence (Hazard Ratio =1.15, p=4.7e-08); AUDIT-C PRS was not an independent 
predictor of any phenotype. In ALSPAC, the AUDIT-C PRS was associated with alcohol 
dependence (R2=0.96%, p=4.8e-6). In GS, AUDIT-C PRS was a better predictor of weekly 
alcohol use (R2=0.27%, p=5.5e-11), while AUDIT-P PRS was more associated with problem 
drinking (R2=0.40%, p=9.0e-7). Lastly, AUDIT-P PRS was associated with ICD-based alcohol-
related disorders in the UKB subset (R2=0.18%, p<2.0e-16). 
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CONCLUSIONS 
AUDIT-P PRS was associated with a range of alcohol-related phenotypes across population-
based and ascertained cohorts, while AUDIT-C PRS showed less utility in the ascertained 
cohort. We show that AUDIT-P is genetically correlated with both use and misuse and 
demonstrate the influence of ascertainment schemes on PRS analyses.  
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INTRODUCTION 
Alcohol use, across the lifespan, can be characterized by a series of transitions: from early 
experimentation to hazardous drinking and possible development of alcohol use disorders 
(AUD), or to non-problematic alcohol intake. Some of these transitions are developmentally 
salient: for instance, hazardous drinking is common during adolescence and early adulthood, 
but does not always portend problematic use in later adulthood (Degenhardt et al., 2013; 
Wennberg, Andersson, & Bohman, 2000). Similarly, individuals with AUD might remit, even to 
abstinence, or persist into later life (McCutcheon et al., 2012; Trim, Schuckit, & Smith, 2013). 
Furthermore, alcohol-related behavior can be broadly disarticulated into two components – the 
extent to which an individual consumes alcohol and the potential problems that they experience 
related to their intake. For instance, AUD are characterized not by excessive alcohol 
consumption but by measurable physiological changes that accompany addiction (e.g. 
withdrawal, tolerance) as well as loss of control over drinking and drinking despite physical and 
emotional impairment (American Psychiatric Association, 2013). These complexities underlying 
the life course of alcohol use and misuse pose challenges in the dissection of etiology. 
  
Most stages of alcohol involvement include a heritable contribution (twin h2 = 40-70%), although 
the magnitude of these genetic effects varies considerably across development (Edwards et al., 
2017; Enoch, 2006; Pagan et al., 2006). Common genetic variants from genome-wide 
association studies (GWAS) explain 4-13% of the phenotypic variance in alcohol use and 
misuse (Clarke et al., 2017; Kranzler et al., 2019; Liu et al., 2019; Sanchez-Roige et al., 2017; 
Schumann et al., 2016; Walters et al., 2018). The largest GWAS of alcohol dependence to date 
(Kranzler et al., 2019) suggests that the genetic correlation between alcohol consumption (units 
per week) and ICD coded AUD is variable (rg ranging from 0.54 (beer/cider) to 0.004 
(champagne/white wine)). 
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A recent study (Sanchez-Roige et al., 2018) conducted GWAS of both the consumption and 
problem subscales of the Alcohol Use Disorders Identification Test (AUDIT), a short screener 
for drinking in the past year (Saunders et al.,1993). In the UK Biobank sample, genetic liability to 
the consumption subscale (AUDIT-C; three items with information pertaining to alcohol 
consumption) was positively correlated with educational achievement and unrelated to 
psychopathology whereas liability to the problem subscale (AUDIT-P; seven items with 
information pertaining to alcohol problems) was negatively correlated with educational 
achievement and positively correlated with psychopathology. These findings are consistent with 
the lack of genetic correlation between psychiatric illness and genetic liability to alcohol 
consumption in the largest GWAS of the trait (drinks per week; Liu et al., 2019). In contrast, two 
recent studies suggest moderate genetic correlations between AUD and consumption indices, 
including the AUDIT-C (e.g., rg = 0.52, p = 2.40e-42) (Kranzler et al., 2019; Marees et al., 2019), 
while another study found that polygenic risk scores (PRS) for past week alcohol consumption 
predicted a modest but significant amount of variance in AUD (e.g., R2 = 0.56%; Johnson et al., 
2019), suggesting that the genetic correspondence between recent consumption and 
dependence may be complicated by several factors, including the characteristics of the sample, 
and the nature of the assessment (e.g., alcohol quantity vs. frequency (Marees et al., 2019)).   
 
In this study, we sought to examine the extent to which PRS derived from the AUDIT-C and 
AUDIT-P GWAS predicted variance in multiple aspects of alcohol use and misuse, ranging from 
levels of alcohol consumption, hazardous drinking, and AUD, in four independent samples that 
vary in their age and ascertainment scheme. PRS are scores that represent an individual’s 
genetic liability for a certain trait or disorder, created by aggregating the effects of many risk 
variants for the phenotype of interest, weighting the effect sizes by the number of effect alleles 
an individual carries at each locus. Prior evidence indicates that association between PRS and 
phenotype in the target sample is improved when both the discovery and target samples for 
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PRS analyses are derived using similar ascertainment strategies (Savage et al., 2018). Based 
on a study showing positive correlations between psychopathology and AUDIT-P (but not 
AUDIT-C; Sanchez-Roige et al., 2018), we hypothesized that AUDIT-P PRS would be more 
closely related to liability to AUD than would AUDIT-C PRS, which would be more closely 
related to aspects of alcohol consumption (e.g., regular consumption, units per week). We also 
hypothesized that associations with AUDIT-C would be stronger in the youngest sample while 
the AUDIT-P would be more predictive of drinking in older, ascertained samples in which 
problem drinking is more established. While there have been some recent studies examining 
the genetic overlap between alcohol consumption and indices of problem drinking (e.g., 
Johnson et al., 2019), none have yet compared the performance of consumption (AUDIT-C) 
versus problem drinking (AUDIT-P) PRS across multiple samples. Taken together, the current 
analyses demonstrate how genetic findings derived from a simple and fast screening tool could 
serve to outline the polygenic underpinnings of different stages of alcohol use and problems in 
diversely ascertained samples. 
  
MATERIALS AND METHODS 
  
Discovery GWAS 
The summary statistics of the recent GWAS of AUDIT-C and AUDIT-P in 121,604 unrelated 
individuals of European ancestry from the UK Biobank cohort (Sanchez-Roige et al., 2018) were 
used to construct PRS for alcohol-related outcomes in four independent target samples. The UK 
Biobank (UKB, www.ukbiobank.ac.uk) is a population-based sample of 502,629 participants 
who were recruited from 22 assessment centers across the United Kingdom from 2006 to 2010 
(Bycroft et al., 2018); the AUDIT was delivered as part of the online Mental Health 
Questionnaire follow-up (Davis et al., 2018). Discovery GWAS analyses were performed using 
BGENIE (Bycroft et al., 2018), version 1.1, with AUDIT scores (AUDIT-C score, and AUDIT-P 
  
 
7 
score, tested independently) as the outcome variable and age, sex, genotyping array, and the 
first 20 principal components derived from genotype data as covariates to account for any 
remaining population stratification. Further details regarding the discovery GWAS are provided 
in the Supplemental Materials. 
  
Target sample demographics and characteristics  
Collaborative Study on the Genetics of Alcoholism 
The Collaborative Study on the Genetics of Alcoholism (COGA) (Begleiter et al., 1995; 
Nurnberger et al., 2004; Schuckit et al., 2018) includes probands meeting criteria for alcohol 
dependence, their family members, and community control families. There were 7,645 
participants of European ancestry with genotype data available as well as data on alcohol-
related phenotypes; of these, 6,850 were ≥20 years (the mean age of onset of alcohol 
dependence) and reported lifetime alcohol use.  
  
Avon Longitudinal Study of Parents and Children 
The Avon Longitudinal Study of Parents and Children (ALSPAC) recruited 14,541 pregnant 
women residing in Avon, UK, with expected dates of delivery April 1, 1991, to December 31, 
1992. The enrolled sample consisted of 14,775 children. Additional details are provided in the 
Supplemental Materials. For the current analyses, phenotypic data were available for up to 
5,911 participants, depending on the phenotype and wave of assessment. Ethical approval for 
the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research 
Ethics Committees. 
  
Generation Scotland 
The Scottish Family Health Study (GS) is a family-based cohort recruited from the general 
population of Scotland from 2006-2011 (N=24,084) (Smith et al., 2013). A subset of GS 
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participants responded to a re-contact in 2015 (Navrady et al., 2018) and provided additional 
information on mental health, which included information on alcohol misuse (N = 17,461).  
  
UK Biobank 
Individuals who were part of the AUDIT discovery GWAS (Sanchez-Roige et al., 2018) were 
removed from the UKB target sample, leaving 245,947 individuals with phenotypic data for 
these analyses.  
  
Alcohol use measures 
A summary of the alcohol-related outcomes included in the analyses is presented in Table 1. 
Across all samples, participants who did not endorse lifetime alcohol use were removed to 
account for those with high genetic liability who elect not to drink for personal or socio-cultural 
reasons, or were not old enough to have had a first drink. Each target sample used a different 
assessment. Details regarding each assessment are available in the Supplementary 
Materials. Briefly, COGA participants were administered the Semi-Structured Interview for the 
Genetics of Alcoholism (SSAGA; (Bucholz et al., 1994)), which includes diagnostic assessments 
for DSM-IV and DSM-5 AUD as well as other aspects of alcohol use. ALSPAC participants 
completed the AUDIT questionnaire, and DSM-IV alcohol dependence was derived for 4,328 
participants, using symptom-level items adapted from (Kendler, et al., 1992). In GS, participants 
reported on their alcohol intake (units per week) using a pre-clinical questionnaire, and were 
also administered the CAGE (Cut-Annoyed-Guilty-Eye) screener (Ewing, 1984). In the UKB, 
ICD-9 and 10 codes for AUD were derived from linkage to hospital inpatient records. Phenotypic 
correlations between alcohol use measures across the samples are shown in Supplementary 
Table 16. 
  
Genotypes 
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Details on genotyping and quality control are shown in the Supplementary Materials.  
  
Polygenic risk score construction 
For all samples, PRS were coded for every individual by multiplying an individual’s number of 
effect alleles at a particular SNP by that SNP’s effect size (beta) from the discovery GWAS 
(Sanchez-Roige et al., 2018) then averaging across SNPs to create one score per person. The 
discovery GWAS summary statistics were clumped using PLINK (Chang et al., 2015; Purcell et 
al., 2007) using the linkage disequilibrium (LD) pattern from the 1000 Genomes European 
(Consortium, 2015) reference sample, with an LD threshold of r2≥0.25 and a 500 kb physical 
distance. PRS were constructed for 8 thresholds (pT<0.0001, pT<0.001, pT<0.01, pT<0.10, 
pT<0.20, pT<0.30, pT<0.40, pT<0.50) and standardized using the scale function in R within each 
sample to ease interpretation of effect sizes. For ALSPAC and COGA, PRS were generated 
using PLINK; for UKB and GS samples, PRS were created using PLINK implemented in PRS-
ice2 (Euesden et al., 2014) using the same R2 thresholds for clumping and the same p-value 
thresholds.  
  
Statistical Analyses 
Linear and logistic regression models were used to examine whether AUDIT-C and AUDIT-P 
PRS were associated with each of the alcohol-related phenotypes (see Table 1), and to 
determine which PRS threshold (i.e., pT) was most predictive of each measure based on the p-
value and observed (linear) or pseudo (logistic) R2. For the cohorts of unrelated individuals 
(ALSPAC and UKB), the partial R2 was extracted from linear regression models for continuous 
traits, while Nagelkerke’s pseudo-R2 was extracted from logistic regression models for binary 
traits. For the cohorts that employed mixed-effect models to account for within-sample 
relatedness (COGA and GS), variance explained by the PRS in the continuous outcomes (e.g. 
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MaxDrinks, CAGE) was calculated by multiplying the PRS by its regression coefficient and 
dividing the variance of that value by the variance of the outcome to derive a coefficient of 
determination between 0 and 1 (Nakagawa & Schielzeth, 2012); in COGA, the ‘MuMIn’ package 
in R was used to calculate marginal R2 for the logistic mixed-effect models for the binary 
outcomes (Barton, 2011). Once the most predictive AUDIT-C and AUDIT-P PRS thresholds 
were determined in the single-PRS models (n.b. pT was allowed to vary between AUDIT-C and 
AUDIT-P PRS), the most predictive PRS for both AUDIT-C and AUDIT-P PRS were 
simultaneously entered into a joint regression model along with covariates (results for single-
PRS models are in available in Supplemental Table 1-12). We primarily report on the results of 
the joint (AUDIT-C PRS + AUDIT-P PRS) regression models, as we wished to examine the 
relative contribution of each AUDIT subscale PRS while controlling for the other subscale PRS. 
As the primary analyses consisted of 2 tests (AUDIT-C PRS and AUDIT-P PRS) for each of the 
12 outcomes, and the number of independent tests across the PRS p-value thresholds was 
estimated to be approximately 5 (calculated using spectral decomposition, via the matSpD.R R 
script (Nyholt, 2004)), we corrected for 120 tests using a Bonferroni p-value = 0.0004.    
  
COGA: Sex, 4 ancestral principal components (chosen via visual inspection of a scree plot of 
the eigenvalues), total number of interviews, birth cohort (born 1890-1929, 1930-1949, 1950-
1969, ≥1970), and array type (see Supplemental Materials) were included as fixed effects, 
while the family identifier and recruitment site were included as random effects (family nested 
within site).  
  
ALSPAC: In keeping with standard practice for genetic analyses in ALSPAC, sex and 10 
ancestral principal components were included as covariates. ALSPAC assessments are age-
specific, therefore age was not included as a covariate.   
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GS: Analyses were performed in AS-REML-R fitting pedigree information as a random effect to 
control for relatedness in the sample. Fixed effects included age, sex and 4 multidimensional 
scaling components to correct for population stratification.   
 
UKB: Age, sex and 10 ancestry principal components were used as covariates.  
  
Cox proportional hazards survival models for onset of hazardous drinking (AUDIT total score 
≥8) in ALSPAC and DSM-IV alcohol dependence in COGA were fit to the data with identical 
covariates as the regression analyses. Those who did not meet criteria for hazardous drinking 
or alcohol dependence were censored at their age at last interview (since age at birth). For ease 
of comparison across the two samples, the same PRS threshold (pT < 0.5) was used in both 
COGA and ALSPAC and for both the AUDIT-C and AUDIT-P PRS. Violations of the proportional 
hazards assumption for the PRS were tested using scaled Schoenfeld residuals. All analyses 
were conducted in R (R Core Team, 2017). In COGA, family identifier and recruitment site were 
included in the survival models as a nested frailty term (i.e. `(1 | site/family)`), using the “coxme” 
package for mixed-effect Cox proportional hazards models containing Gaussian random effects 
(Therneau, 2018). ALSPAC data were analyzed using the “survival” and “survminer” packages 
in R (Kassambara et al., 2017; Therneau & Lumley, 2015) 
 
For illustrative purposes, PRS were also split into quartiles for COGA, ALSPAC, and UKB, and 
the odds of having an AUD diagnosis (DSM-IV alcohol dependence in COGA and ALSPAC, 
ICD-9/ICD-10 alcohol related codes in UKB) was calculated in each quartile using the lowest 
quartile as the reference group.  
   
RESULTS 
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Target sample demographics and characteristics 
The prevalence of each alcohol use measure for each target sample is shown in Table 1. The 
SNP-heritability of AUDIT-C was 11%, while the SNP-heritability of the AUDIT-P score was 9%, 
and the genetic correlation (i.e., SNP-rg) between them was rg = 0.70 (as reported in the original 
paper (Sanchez-Roige et al., 2018)). See Supplemental Table 15 for the number of SNPs in 
each PRS threshold. 
  
COGA: 33.8% of the participants (N = 2,318) met DSM-IV criteria for alcohol dependence 
during their lifetime, with 77.6 % of those endorsing ≥6 (i.e., severe) DSM-5 AUD criteria. A 
median of 14.0 drinks (SD = 12.9; ~96 grams of alcohol, or 14 standard US drinks) in a single 
24-hour period was reported (i.e., MaxDrinks). 90.0% of the participants reported drinking at 
least once a month for 6 consecutive months or longer (i.e., monthly alcohol use).  
ALSPAC: By age 23, 11.2% (N = 484) had met DSM-IV criteria for alcohol dependence within 
the past year at any of the three assessment waves, while 66.2% reported hazardous drinking 
(AUDIT total score ≥8). The median MaxDrinks was 15 UK units (SD = 12.4; approximately 120 
grams of alcohol, or 8.5 standard US drinks).  
GS: Mean alcohol intake was 10.9 units per week (SD = 12.8; approximately 87.2 grams of 
alcohol, or 6.2 standard US drinks; N = 17,461) and the mean CAGE score was 0.6 (SD = 0.93). 
UKB: There were 4,141 (1.68%) individuals in the subset of UKB selected for analysis who had 
at least one ICD-9 or ICD-10 code assigned as a primary or secondary diagnosis of alcohol 
related disorders during time as a hospital inpatient. 
  
Associations between AUDIT PRS and consumption measures  
COGA: As shown in Table 2, only the AUDIT-P PRS was significantly associated with monthly 
alcohol use (R2= 0.65%, p = 1.24e-4) and MaxDrinks (R2= 0.47%, p = 2.00e-8). We also 
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converted the pseudo-R2 values for all binary outcomes to R2 on the liability scale (Lee et al., 
2012), but as estimates did not differ, these results are not presented. 
ALSPAC: AUDIT-C and AUDIT-P PRS accounted for increasing proportions of phenotypic 
variance in AUDIT-C and AUDIT-P scores as the sample aged, from ~0.50% at age 16 to 
1.12% at age 23 (see Supplementary Tables 8-9 for complete results). Here we focus on 
results for age 23 for comparability to other samples, which consisted predominantly of adults. 
No association survived the correction for multiple tests. The strongest associations observed 
were for AUDIT-C and AUDIT-P PRS, which were both associated with higher AUDIT-C scores 
in ALSPAC at age 23, each explaining 0.60% of the variance (p = 1.06e-3 and 5.9e-4, 
respectively), and between AUDIT-P PRS and MaxDrinks (R2= 3.30%, p = 1.59e-3); a 1-SD 
increase in AUDIT-P PRS corresponds to a predicted increase of 0.54 drinks. 
GS: The AUDIT-P PRS explained 0.15% of the variance in units per week (p = 4.7e-7) and 
0.40% of the variance in CAGE scores (p = 9.0e-7), while the AUDIT-C PRS explained 0.27% of 
the variance in units per week (p = 5.5e-11). 
  
Associations between AUDIT PRS and alcohol problem measures 
COGA: As shown in Table 2, only the AUDIT-P PRS was significantly associated with DSM-IV 
alcohol dependence (R2 = 0.68%, p = 4.55e-9) and DSM-5 AUD symptom count (R2 = 0.67%, p 
= 1.01e-10). For individuals in the top quartile of AUDIT-P PRS risk, the odds of being 
diagnosed with alcohol dependence was 1.74 (95% confidence intervals (C.I.) = 1.47-2.07) 
compared to those in the lowest quartile, while being in the top AUDIT-C PRS quartile was 
associated with an odds ratio (OR) of 1.30 (95% C.I. = 1.10 -1.54) compared to those in the 
lowest quartile (Figure 1). Comparison of the OR and their 95% C.I. suggest that for AUDIT-C, 
those in the 4th quartile are at significantly elevated likelihood of AUD compared to those in 
lowest quartile, though there were overlapping 95% C.I. between the 2nd, 3rd, and 4th quartiles. 
In contrast, for AUDIT-P, likelihood of AUD escalates at the mid-point, with those in the both the 
  
 
14 
3rd and 4th quartiles being at significantly greater risk of AUD than those in the lowest quartile 
of AUDIT-P PRS. 
ALSPAC: Only AUDIT-P PRS were associated with AUDIT-P scores, accounting for 1.1% of the 
variance (p = 9.05e-6). AUDIT-C PRS and AUDIT-P PRS were both positively associated with 
DSM-IV alcohol dependence, explaining 1.0% (p = 4.81e-6) and 0.50% (p = 5.75e-4) of the 
variance, respectively, although only the AUDIT-C PRS passed multiple testing corrections. 
Both PRS scores were also positively associated with DSM-IV alcohol dependence symptom 
count (R2 = 0.8% for both; AUDIT-C p = 3.59e-5, AUDIT-P p = 3.53e-5). For individuals in the 
top quartile of AUDIT-C PRS, the odds of being diagnosed with AUD was 1.73 (95% C.I. = 1.29-
2.33) compared to those in the lowest quartile, while being in the top AUDIT-P PRS quartile was 
associated with an OR of 1.25 (95% C.I. = 0.93 -1.68) compared to those in the lowest quartile 
(Figure 1). Due to wider 95% C.I. (suggesting imprecision potentially due to smaller sample size 
and/or less of a dose-response association pattern), it was difficult to draw comparisons of the 
ORs across quartiles in the ALSPAC sample. For AUDIT-C, differentiation in likelihood of AUD 
appeared to occur at the 3rd quartile, while for AUDIT-P, there was no clear distinction in the 
OR across the 2nd, 3rd and 4th quartiles. 
UKB: Positive associations with AUD-related ICD codes were observed for both AUDIT-P (R2 = 
0.18%, p < 2e-16) and AUDIT-C (R2 = 0.04%, p = 8.9e-5) PRS. For individuals in the top quartile 
of AUDIT-P PRS, the odds of having a mental or behavioral disorder due to alcohol was 1.45 
(95% C.I. = 1.37-1.54) compared to those in the lowest quartile. For AUDIT-C PRS, being in the 
top PRS quartile was associated with an odds-ratio of 1.11 (95% C.I. = 1.02-1.20) compared to 
those in the lowest quartile (Figure 1).  In the UKB, likelihood of AUD across quartiles seemed 
to follow a dose-response pattern with increasing OR for each quartile of polygenic risk for both 
AUDIT-C and AUDIT-P (though with overlapping C.I. for AUDIT-C), with the 4th quartile of 
AUDIT-P PRS being statistically significantly more likely to be diagnosed with AUD relative to 
the 3rd quartile. 
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Associations between AUDIT PRS and onset of hazardous drinking and alcohol 
dependence 
COGA: The AUDIT-P, but not the AUDIT-C, PRS was associated with increased hazards of 
alcohol dependence onset (AUDIT-P HR = 1.15, 95% CI = 1.10-1.20, p = 4.7e-08; 
Supplemental Table 13). Those in the top quartile of AUDIT-P PRS were at considerably 
higher risk for onset of alcohol dependence (HR = 1.50, 95% CI = 1.36-1.64, p = 9.7e-10) 
relative to any other group; the risk attributable to the top AUDIT-C PRS was lower in magnitude 
(HR = 1.27, 95% CI = 1.14-1.40, p = 1.8e-4).  
ALSPAC: Only the AUDIT-C PRS was associated with onset of hazardous drinking, although 
not significant after multiple testing corrections (Supplemental Table 14; AUDIT-C HR = 1.06, 
95% CI = 1.02-1.10, p = 2.28e-3). 
  
DISCUSSION 
The course of alcohol use and misuse consists of several stages, each with polygenic and 
environmental underpinnings. At earlier ages, how much and how often a person drinks often 
serves as an indicator of their genetic susceptibility to alcohol misuse (Dick et al., 2011; Irons et 
al., 2015). As an individual progresses towards maladaptive alcohol intake, a unique genetic 
susceptibility to physiological and psychological impairments related to alcohol misuse may 
unfold (Kendler et al., 2011). Our goal was to outline the extent to which PRS derived from a 
discovery GWAS of the AUDIT consumption (AUDIT-C) and problem (AUDIT-P) subscales 
predicted variance in a range of alcohol use behaviors across samples that were variously 
ascertained. With few exceptions, polygenic liability to AUDIT-P was a superior predictor of 
indices of heavy drinking and alcohol problems compared to the AUDIT-C.  
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Overall, across several ascertainment strategies, AUDIT-P PRS outperformed AUDIT-C as a 
predictor of both normative and disordered drinking (see Figure 2 for an overview). For 
example, AUDIT-P PRS predicted up to 3.3% of the variance in the lifetime maximum number of 
drinks consumed in a 24-hour period (although this was a clear outlier in terms of variance 
explained), 1.1% of the variance in AUDIT-P scores, and 0.7% of the variance in DSM-5 AUD 
symptom counts. Exceptions to the superior performance of AUDIT-P PRS were observed 
within ALSPAC, where AUDIT-C PRS explained higher proportions of variance than AUDIT-P 
PRS in some adolescent AUDIT-C and AUDIT-P assessments (prior to age 23; see 
Supplemental Materials). AUDIT-C PRS also accounted for more variance in DSM-IV AD in 
ALSPAC. 
 
Even indices of alcohol consumption, such as lifetime maximum drinks in 24 hours and monthly 
alcohol use, were more closely related to the genetic liability indexed by AUDIT-P PRS than 
AUDIT-C PRS. However, this difference was most notable in COGA, for which drinking for at 
least 6 months during the lifetime represents a highly heterogeneous group of individuals, which 
may include both non-problem drinkers and those with AUD. As expected, and in line with prior 
studies (Mies et al., 2018; Sanchez-Roige et al., 2018), AUDIT-P outperformed AUDIT-C for 
measures of problem drinking within each sample (i.e., COGA, ALSPAC, GS and UKB; see 
Table 2), confirming that the AUDIT-P is more closely related to genetic susceptibility to alcohol 
misuse than AUDIT-C.  
 
Overall, the variance explained by PRS was low, even when the discovery and target 
phenotypes were identical (e.g. AUDIT scores in ALSPAC). These estimates are nonetheless 
consistent with other PRS studies (Mies et al., 2018; Savage et al., 2018), and the proportion of 
explained variance may improve as the discovery GWAS get larger. In agreement with previous 
studies (Savage et al., 2018), we demonstrated that ascertainment is likely to be a crucial factor 
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in polygenic prediction analyses. For instance, while the AUDIT-P PRS explained a larger 
amount of variance in dependence in COGA than in ALSPAC, the AUDIT-C PRS was not a 
significant predictor for any phenotype in COGA over and above the effect of AUDIT-P PRS, 
suggesting that the effect sizes for AUDIT-C from a volunteer cohort (UKB) may not be optimal 
for capturing genetic risk to AUD in high-risk families, such as those in COGA. AUDIT-C 
associations in COGA using other addiction-enriched samples, such as the Million Veteran 
Program (Kranzler et al., 2019), where the genetic correlation between AUDIT-C and AUD is 
high, will likely provide insights into the extent of the effect of ascertainment differences in 
discovery and target samples. Interestingly, variance explained by either PRS was the highest 
in ALSPAC, a population-based cohort that is noticeably younger than the discovery sample 
(age 39-79 years). Lastly, the variance explained for AUD in the (independent) subset of UKB 
participants itself was markedly lower than in ALSPAC. Here, it is worth recognizing that AUDIT 
is a past-year screener for alcohol consumption/problems, and there may have been individuals 
in the original AUDIT GWAS with low scores who were formerly problem drinkers. Furthermore, 
using ICD codes derived from hospital records as a proxy for AUD in the UKB may have 
resulted in false negatives; some of the 'controls' could have been problem drinkers but had not 
been  diagnosed with an alcohol related condition as a hospital inpatient. Thus, the lower 
prediction in the UKB sample may reflect the instruments used to measure AUD in both the 
discovery and target GWAS.  
 
Our findings should be viewed in the context of several limitations. First, the AUDIT is a past-
year screener for alcohol consumption and problems, and thus may not capture individuals who 
had alcohol use problems in the past. Second, the AUDIT discovery GWAS was performed in a 
subset of the UKB that consisted of individuals who responded to an email request to complete 
a mental health follow-up survey. A recent study of the genomic profiles of these individuals has 
found them to represent lower polygenic risk for psychopathology and greater polygenic load for 
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educational achievement, suggesting selection bias in the discovery sample itself (Adams et al., 
2018). In addition, these individuals had relatively low endorsement of AUDIT-P items, which 
might have limited the statistical power of the discovery GWAS to capture the full spectrum of 
problem drinking and, in turn, limited our ability to compare across the AUDIT-C and AUDIT-P.  
Third, as the discovery GWAS was conducted on individuals of primarily European descent, 
these PRS could not be applied to other ancestral groups, reflecting a research gap in the 
dearth of large discovery GWAS of non-European populations (Martin et al., 2017). Results from 
the recent AUDIT-C GWAS by Kranzler et al (2019), which includes 57,340 African-Americans, 
for instance, will be instrumental in bridging this gap. Fourth, it is likely that the pattern of results 
reflects a complex interplay between developmental effects, ascertainment strategy, the 
psychometrics of the assessment instruments, and even population selection effects. For 
instance, distinctions between ALSPAC and COGA could be attributed to the higher median age 
of COGA participants, or even drinking patterns prevalent in earlier birth cohorts that are 
represented within COGA. Potential moderation of PRS by sex are also possible; however, 
power for such exploratory analyses is limited and beyond the scope of this study. Fifth, 
although this study examined a range of alcohol use phenotypes (from a measure of monthly 
alcohol use to dependence), the cross-sectional design cannot capture potential longitudinal 
changes in PRS association across the progression of stages of alcohol use. A sixth limitation is 
that we did not control for any measures of socioeconomic status (SES) in our models, although 
SES has been shown to be a potential moderator of polygenic risk for alcohol consumption 
(Clarke et al., 2016; Barr et al., 2018), as the measures available varied widely and 
inconsistently across our target samples. The imbalance of cases and controls in the UK 
Biobank target sample is another limitation; this imbalance would be more likely to seriously 
bias a discovery GWAS, but may still have confounded the regression analyses in our target 
sample. A final limitation is that the strength of PRS associations varied across p-value 
thresholds (pT; see Supplementary Tables 1-12); because we chose the best-performing pT for 
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each model, as is typical for the pruning+thresholding (P+T) method of polygenic risk score 
analyses (Euesden et al., 2014), we run the risk of over-fitting.   
 
Collectively, these analyses demonstrate that much of the polygenic liability to alcohol use and 
misuse remains unaccounted for – we anticipate that much larger GWAS of phenotypes 
representing disordered drinking, in conjunction with other risk indices (e.g., PRS for negative 
affect, a hallmark of later stages of AUD) will be necessary to explain additional variance. 
Importantly, as the use of PRS becomes increasingly common in attempts to dissect the 
transitions from experimentation, to regular or problem use and further, to AUD, differences 
between the discovery sample and target sample(s) in age, ascertainment, and other 
characteristics will need to be considered in the interpretation of findings. In addition, our 
findings highlight the high degree of heterogeneity and polygenicity underlying alcohol use and 
misuse – not only is there no “gene for” alcoholism, there is currently no robust “polygenic 
indicator for” clinical prediction of liability to problem drinking. Furthermore, while we focused on 
contrasting the genetic relationship of each individual AUDIT subscale with the variety of 
alcohol-related measures across our different samples, it should be noted that the proportion of 
variance explained in the alcohol-related outcomes is larger when we consider both the AUDIT-
C and AUDIT-P PRS together, suggesting that multiple polygenic scores provide more utility 
than PRS for the individual sub-scales. The two scores are only modestly correlated and likely, 
some of this commonality is due to variants in ADH1B that exert a relatively large effect. Overall, 
our analyses suggest that even though it is far too small to be statistically significant, there is 
some incremental contribution of variance from inclusion of the AUDIT-C. Despite these 
caveats, our analyses demonstrate the feasibility of using a fast and simple screening 
questionnaire, the AUDIT, that assesses both consumption and problem drinking, to understand 
the course of alcohol use and misuse. 
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TABLES 
 
Table 1. Alcohol-related measures in each target sample. C, Continuous (linear regression model used); B, Binary 
(logistic regression model used) 
Drinking measure Definitions 
Trait 
Continuous/ 
Binary 
COGA  
Ascertained for AUD 
ALSPAC 
Population-based 
GS 
Population-
based 
UKB 
Population-
based 
Units per week 
(Mean, SD) 
C n/a n/a 10.9 (12.8) n/a 
Alcohol use 
(N, %) 
B 
Ever drank once a 
month for 6 
consecutive months or 
longer 
6,163 (90.0%) 
n/a n/a n/a 
Maxdrinks 
(Median, SD) 
C 
Lifetime maximum 
drinks consumed in a 
single 24-hour period 
14.0 (12.87) 
Lifetime maximum drinks 
consumed in a single 
24-hour period 
15.0 (12.35) 
n/a n/a 
Hazardous 
drinking (N, %) 
B n/a 
AUDIT total score cutoff 
of 8+ at any age 
3264 (66.2%) 
n/a n/a 
AUDIT-C score 
(Mean, SD) 
C n/a 
Sum of AUDIT items 1-3 
Age 16 4.80 (2.59) 
Age 18 5.04 (2.26) 
Age 19 6.01 (2.50) 
Age 21 6.11 (2.43) 
Age 23 5.37 (2.31) 
n/a n/a 
AUDIT-P score 
(Mean, SD) 
C n/a 
Sum of AUDIT items 4-
10 
Age 16 2.37 (3.18) 
Age 18 2.48 (2.97) 
Age 19 2.38 (2.89) 
Age 21 3.16 (3.66) 
Age 23 2.30 (2.93)   
n/a n/a 
DSM alcohol 
dependence 
symptom count 
(Mean, SD) 
C 
Sum of 11 lifetime 
criteria for diagnosis of 
DSM-5 AUD 
3.57 (3.68) 
Sum of 7 criteria for 
diagnosis of DSM-IV 
AUD; maximum 
observed across waves 
Age 18 0.35 (0.91) 
Age 21 0.72 (1.30) 
Age 23 0.43 (1.01) 
n/a n/a 
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DSM-IV alcohol 
dependence 
diagnosis 
(N, %) 
B 
Clustering of ≥3 of 7 
DSM-IV criteria within 
12 months 
2,318 (33.8%) 
Clustering of ≥3 of 7 
DSM-IV criteria within 12 
months at any wave of 
assessment (age 18, 21, 
or 23)  
484 (11.2%) 
n/a n/a 
ICD-9 and ICD-
10 alcohol 
dependence 
diagnosis (N, %) 
B n/a n/a n/a 
ICD-9 code of 
303* or ICD-
10 code of 
F10* 4,141 
(1.68%) 
CAGE scores 
(Range 0-4; 
Mean, SD) 
C n/a n/a 0.603 (0.93) n/a 
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Table 2. Associations between AUDIT-C and AUDIT-P PRS and multiple indices of alcohol use in COGA, UKB, ALSPAC and GS samples. 
The PRS threshold (pT) that most strongly predicted each outcome (based on highest R2) is presented. Results significant at p < 0.0004 are bolded. 
Complete results are available in Supplemental Tables 1-12. 
  
AUDIT-C PRS AUDIT-P PRS 
Outcome Sample pT R2 Beta (SE) p-value pT R2 Beta (SE) p-value 
Units per Week GS <0.1 0.27% 0.052 (0.008) 5.50E-11 <0.01 0.15% 0.039 (0.008) 4.70E-07 
Alcohol use COGA <0.0001 0.32% 0.129 (0.046) 5.19E-03 <0.4 0.65% 0.188 (0.049) 1.24E-04 
AUDIT-C  ALSPAC (age 23) <0.1 0.59% 0.066 (0.020) 1.06E-03 <0.01 0.65% 0.067 (0.020) 5.90E-04 
Max Drinks ALSPAC   <0.5 1.54% 0.389 (0.173) 2.44E-02 <0.2 3.26% 0.540 (0.171) 1.59E-03 
COGA  < 0.001 0.04% 0.266 (0.147) 7.03E-02  < 0.2 0.47% 0.879 (0.156) 2.00E-08 
CAGE GS <0.4 0.19% 0.044 (0.010) 8.60E-04 <0.2 0.40% 0.063 (0.010) 9.00E-07 
AUDIT-P ALSPAC (age 23) <0.2 0.28% 0.045 (0.020) 2.61E-02 <0.01 1.12% 0.088 (0.020) 9.05E-06 
Alcohol Dependence 
Symptom Count 
ALSPAC (DSM-IV) <0.3 0.84% 0.091 (0.022) 3.59E-05 <0.01 0.84% 0.086 (0.021) 3.53E-05 
COGA (DSM-5)  < 0.1 0.08% 0.103 (0.045) 2.30E-02  < 0.4 0.67% 0.301 (0.046) 1.01E-10 
Alcohol Dependence ALSPAC (DSM-IV) <0.3 0.96% 0.240 (0.052) 4.81E-06 <0.01 0.54% 0.170 (0.050) 5.75E-04 
COGA  (DSM-IV) <0.0001 0.14% 0.078 (0.032) 1.44E-02 <0.4 0.68% 0.199 (0.034) 4.55E-09 
UKB (ICD) <0.0001 0.04% 0.062 (0.016) 8.90E-05 <0.5 0.18% 0.147 (0.020) < 2.00E-
16 
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FIGURE CAPTIONS 
Figure 1. Odds Ratios (OR) and 95% confidence interval for alcohol dependence 
diagnosis by PRS quartiles in ALSPAC, COGA, and UKB. PRS were split into quartiles and 
odds ratios calculated for case status for each quartile of risk compared to quartile 1 (lowest). A. 
Alcohol dependence in ALSPAC was coded by DSM-IV diagnosis (484 cases, 3,837 controls).  
B. Alcohol dependence was coded via DSM-IV diagnosis in the COGA sample (2,318 cases, 
4,532 controls). C. A sample of European ancestry, unrelated British individuals who had ever 
drank, had ICD9 and ICD-10 codes available, and were not included in the discovery GWAS 
were used (4,141 cases, 241,806 controls). 
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Figure 2. Overview of the magnitude of predicted variance (R2, %) across the alcohol-
related phenotypes probed in the four independent samples (Generation Scotland, GS; 
ALSPAC at age 23, A23; Collaborative Study on the Genetics of Alcoholism, COGA; and 
UK Biobank, UKB). The color of the dots denotes AUDIT-C (light gray) or AUDIT-P (dark gray) 
PRS. Only the significant (p < 0.0004) associations are shown. C, AUDIT-C; P, AUDIT-P. 
 
 
 
